
BioEquity Watch is a free, independent publication offering in-depth analysis of biotech and pharmaceutical companies, focused on market-relevant research, IPOs, and drug development pipelines.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 56 | Founded | a year ago | Last Issue | 2 days ago |
| Active | |||||

Rating: Cautiously Bullish| Target Price: $40.00 | Current Price: $19.13 | Implied Change: +109.1%
MoonLake Immunotherapeutics is a fascinating but highly polarizing story in the small-cap biotech space, where an incre...
Vera Therapeutics is sitting on a massive opportunity in the autoimmune kidney disease space, and we think the stock could climb...
Rating: BULLISH | Target Price: $14.50 | Current Price: $5.36 | Implied Change: +170.5%
We are bullish on ACHV with a price target of $14.50, which is 170.5% upside from here. The market is treating cytisinicline like any...
Edgewise Therapeutics is sitting on a massive pile of cash that completely changes the financial realities for this stock. By sel...
Rating: BULLISH | Target Price: $6.35 | Current Price: $2.13 | Implied Upside: +198%
In short, yes. We are staying highly bullish on Compass Therapeutics with an updated $6.35 target price, which means we see a massive 19...
Subscribers, engagement, traffic and sponsorship for BioEquity Watch.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
BioEquity Watch is a free, independent publication offering in-depth analysis of biotech and pharmaceutical companies, focused on market-relevant research, IPOs, and drug development pipelines.
You can find recent issues that have been published by BioEquity Watch on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to BioEquity Watch, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch BioEquity Watch as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact BioEquity Watch using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like BioEquity Watch. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.